No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PGNY Progyny
- 26.740
- -0.720-2.62%
Close May 22 16:00 ET
2.55BMarket Cap43.84P/E (TTM)
27.510High26.600Low1.45MVolume27.330Open27.460Pre Close38.93MTurnover1.75%Turnover Ratio43.13P/E (Static)95.22MShares44.95052wk High4.45P/B2.21BFloat Cap23.90052wk Low--Dividend TTM82.69MShs Float68.320Historical High--Div YieldTTM3.31%Amplitude13.290Historical Low26.935Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY
Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY
Express News | Progyny Announces $100M Share Repurchase Program Approved By Board Of Directors; To Be Funded Through Available Cash Balances
Express News | Progyny Announces $100M Stock Repurchase Program
Express News | Progyny Inc - Approved a Share Repurchase Program to Repurchase up to $100 Mln of Its Common Stock
Express News | Progyny, Inc. Announces Additional Share Repurchase Program
Analysts Are Bullish on Top Healthcare Stocks: Progyny (PGNY), Regeneron (REGN)
Comments
Progyny's CEO, Pete Anevski, is thrilled about the executive team expansion, confident that the new members' expertise will boost the company's growth in fertility, family building, and women's health benefits. Both Higgins and Leist are excited to contribute to Progyny's growth and innovation.
Press Release: Progyny Expands Its Leadership TeamInvestors may be justifying Progyny's high P/E ratio by betting on its potential to outperform market growth. The company's strong forecast growth is believed to be upholding its high P/E and providing strong support to its share price.
Progyny, with a low ROCE score of 9.2%, underscores promising fundamentals following its foray into profitability. Having offered a notable 27% to shareholders over three years, its developing factors necessitate a deeper analysis for future investment opportunities.
$Progyny(PGNY.US$ Bought in at 64.40 and now what do I do sigh
6
2
$Costco(COST.US$ Costco (COST) target raised by Citigroup from $460 to $495 at Neutral. Stock currently around $448
$Etsy Inc(ETSY.US$ Etsy (ETSY) target raised by Loop Capital from $220 to $245 at Buy. Stock currently around $211
$Generac(GNRC.US$ Generac (GNRC) target raised by Roth Capital from $480 to $500 at Buy. Stock currently around $425
$Fortinet(FTNT.US$ Fortinet (FTNT) target raised by Cowen from $335 to $385 at Outperform. Stock currently around $288
$NVIDIA(NVDA.US$ NVIDIA (NVDA) target raised by Susquehanna from $220 to $250 at Positive. Stock currently around $206
$Progyny(PGNY.US$ Progyny (PGNY) target raiosed by Barclays from $72 to $80 at Overweight. Stock currently around $56
$Etsy Inc(ETSY.US$ Etsy (ETSY) target raised by Loop Capital from $220 to $245 at Buy. Stock currently around $211
$Generac(GNRC.US$ Generac (GNRC) target raised by Roth Capital from $480 to $500 at Buy. Stock currently around $425
$Fortinet(FTNT.US$ Fortinet (FTNT) target raised by Cowen from $335 to $385 at Outperform. Stock currently around $288
$NVIDIA(NVDA.US$ NVIDIA (NVDA) target raised by Susquehanna from $220 to $250 at Positive. Stock currently around $206
$Progyny(PGNY.US$ Progyny (PGNY) target raiosed by Barclays from $72 to $80 at Overweight. Stock currently around $56
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg